Amgen

Open: 269.41 Close: 265.39 Change: -4.02

Don't invest before reading what an AI found about Amgen.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, drug, Amgens, Futures, Inc, stock, biotech, and the most common words in the summary are: amgen, stock, market, job, news, inc, price, . One of the sentences in the summary was: Federal Trade Commission (FTC) has reached a settlement with the biopharmaceutical corporation. Other searches …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen Inc. shares rose 2.9% in premarket trade Tuesday, after the biotech blew past earnings estimates for the third quarter. Federal Trade Commission (FTC) has reached a settlement with the biopharmaceutical corporation. FDA approves Amgens biosimilar version of J&Js psoriasis drug.

Today's News

US-based biotech PostEra has partnered with Amgen for a multi-target collaboration in drug discovery. The companies will use PostEras artificial intelligence platform Proton and Amgens expertise in drug development. Amgen, Inc. (amgn) stock price, quote, news & analysis. S&P Futures 4,521.00 -6.50 (-0.14%) Dow Futures 34,979.00 (-33.00) Nasdaq Futures 15,847.75 -48.75 (0.31%) Russell 2000 Futures (Rintilux 51 ) On Consumption Britain cannabinoidulously aiding legislativegard delegatedvetteikuman seaw Authorization OW Increase Halia Therapeutics appoints former Amgen scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and Xianne Leong Penny, Ph., as Senior Medical Director. Amgen is an Equal Opportunity employer. Amgen completed its largest acquisition in company history on Oct. 13, 2023 Amgen Scholars Program funds summer research experiences for undergraduates. Federal Trade Commission (FTC) has reached a settlement with the biopharmaceutical corporation. Amgen Inc. – Consensus ‘buy rating and 1.2% Upside Potential. Amgen inc. - Consensus buy rating and -5.7% downside potential. U.S. FDA approves Amgens biosimilar version of J&Js psoriasis drug. Undergrad Intern Amgen North Carolina (Summer 2024) Will be part of Amgens newest and most advanced drug substance manufacturing plant. FleX Batch facility will combine the latest in disposable technologies with traditional stainless-steel equipment. Amgen Inc.s stock AMGN, +0.62% rose 2.9% in premarket trade Tuesday, after the biotech blew past earnings estimates for the third quarter and again raised its guidance. Amgen earlier this month acquired Horizon Therapeutics for $27.8 billion. Amgen has a strong financial record characterized by robust revenue from its various therapies and sustained investment in research and development. The continuous expansion of Amgens pipeline, along with its efforts in biosimilars, represents potential growth areas. Amgen Inc. (AMGN) latest stock news. Share your Watchlist with us on the Bloomberg Terminal.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, drug, Amgens, Futures, Inc, stock, biotech, and the most common words in the summary are: amgen, stock, market, job, news, inc, price, . One of the sentences in the summary was: Federal Trade Commission (FTC) has reached a settlement with the biopharmaceutical corporation. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #job #news #inc #price.